Immunohistochemical Detection of TTF-1 in Intraoperative Bioptic Samples of Adenocarcinoma of the Lung: a Year-Long Experience
Authors:
R. Matěj; J. Vedralová; F. Koukolík
Authors‘ workplace:
Oddělení patologie a molekulární medicíny, Fakultní Thomayerova nemocnice s poliklinikou, Praha
Published in:
Čes.-slov. Patol., 44, 2008, No. 2, p. 41-44
Category:
Original Article
Overview
The thyroid transcription factor 1 (TTF-1) is a highly sensitive and specific marker of adenocarcinomas of pulmonary origin in differential diagnosis of solitary pulmonary nodules. Positivity of TTF-1 as a marker of primary pulmonary tumor could have a very high impact on surgical treatment strategy. From known protocols we developed the method of immunohistochemical investigation of intraoperative bioptic samples from frozen section lasting about 15 minutes. During last year, we applied this method on 30 cases of intraoperative bioptic samples. All investigated cases were verified by immunohistochemical examination from formalin-fixed and paraffin-embedded definite tissue samples. With the exception of two samples in which the result was inconclusive from both frozen and fixed tissue, all other samples revealed the same result. Our experience demonstrates that intraoperative immunohistochemical investigation of TTF-1 in proper consequences could be a very useful tool for routine practice.
Key words:
thyroid transcription factor 1 (TTF-1) – intraoperative biopsy – immunohistochemistry – lung adenocarcinoma
Sources
1. Butcher D.N., Goldstraw P., Ladas G., Dusmet M.E., Sheppard M.N., Nicholson A.G.: Thyroid transcription factor 1 immunohistochemistry as an intraoperative diagnostic tool at frozen section for distinction between primary and secondary lung tumors. Arch. Pathol. Lab. Med., 131, 2007, s. 582-587.
2. Barlési F., Pinot D., Legoffic A., et al.: Positive thyroid transcription factor 1 staining strongly correlates with survival of patients with adenocarcinoma of the lung. Br. J. Cancer, 22, 2005, s. 450-452
3. Camilleri-Broet S., Alifano M., Morcos M., et al.: Peroperative frozen section analysis of TTF-1 antigen expression. J. Clin. Pathol., 57, 2004, s. 98–100.
4. Compérat E., Zhang F., Perrotin C., et al.: Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal origin. Mod. Pathol., 18, 2005, s. 1371-1376.
5. Ikeda K., Clark J.C., Shaw-White J.R., et al.: Gene structure and expression of human thyroid transcription factor-1 in respiratory epithelial cells. J. Biol. Chem., 270, 1995, s. 8108-8114.
6. Lazzaro D., Price M., de Felice M., et al.: The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. Development., 113, 1991, s.1093-1104.
7. Moldvay J., Jackel M., Bogos K., et al.: The role of TTF-1 in differentiating primary and metastatic lung adenocarcinomas. Pathol. Oncol. Res., 10, 2004, s. 85-88.
8. Penman D., Downie I., Roberts F.: Positive immunostaining for thyroid transcription factor-1 in primary and metastatic colonic adenocarcinoma: a note of caution. J. Clin. Pathol., 59, 2006, s. 663-664.
9. Sienko A., Allen T.C., Zander D.S., Cagle P.T.: Frozen section of lung specimens. Arch. Pathol. Lab. Med., 129, 2005, s. 1602-1609.
10. Travis W.T., Brambilla E., Müller-Hermelink H.K., Harris C.C.: Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press, Lyon, 2004, s. 9-122.
11. Zamecnik J., Kodet R.: Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases. Virchows Arch., 440, 2002, s. 353-361
Labels
Anatomical pathology Forensic medical examiner ToxicologyArticle was published in
Czecho-Slovak Pathology
2008 Issue 2
Most read in this issue
- Immunohistochemical Detection of TTF-1 in Intraoperative Bioptic Samples of Adenocarcinoma of the Lung: a Year-Long Experience
- Difficulties in Routine Diagnostics of Urothelium Lesions
- Double Immunostaining with CD1a and CD68 in the Phenotypic Characterization of Indeterminate Cell Histiocytosis
- The 2007 World Health Organisation Classification of Tumours of the Central Nervous System, Comparison with 2000 Classification